Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 9
Submit an article Journal homepage
500
Views
6
CrossRef citations to date
0
Altmetric
Author's View

Identification of new prognostic biomarkers for Stage III metastatic melanoma patients

Hojabr Kakavand Melanoma Institute Australia; North Sydney, NSW Australia; The University of Sydney; Sydney, NSW Australia
,
Richard A Scolyer Melanoma Institute Australia; North Sydney, NSW Australia; The University of Sydney; Sydney, NSW Australia; Tissue Pathology and Diagnostic Oncology; Royal Prince Alfred Hospital; Camperdown, NSW Australia
,
John F Thompson Melanoma Institute Australia; North Sydney, NSW Australia; The University of Sydney; Sydney, NSW Australia; Department of Melanoma and Surgical Oncology; Royal Prince Alfred Hospital; Camperdown, NSW AustraliaCorrespondence[email protected]
&
Graham J Mann Melanoma Institute Australia; North Sydney, NSW Australia; The University of Sydney; Sydney, NSW Australia; Westmead Millennium Institute; Westmead, NSW Australia
Article: e25564 | Received 25 Jun 2013, Accepted 27 Jun 2013, Published online: 03 Jul 2013

Figures & data

Figure 1. Factors independently associated with melanoma-specific survival fewer than 4 y on multivariable logistic regression analyses among AJCC Stage III patients. Data are presented as odds ratios with 90% confidence interval. Cell Size, large cell size in nodal metastases; Nodular Component, presence of a nodular component in primary lesions; Pigment, high degree of pigmentation in nodal metastases; Stage II, AJCC Stage II at presentation; Stage III, AJCC Stage III at presentation. Figure modified with permissions from Mann et al.Citation5

Figure 1. Factors independently associated with melanoma-specific survival fewer than 4 y on multivariable logistic regression analyses among AJCC Stage III patients. Data are presented as odds ratios with 90% confidence interval. Cell Size, large cell size in nodal metastases; Nodular Component, presence of a nodular component in primary lesions; Pigment, high degree of pigmentation in nodal metastases; Stage II, AJCC Stage II at presentation; Stage III, AJCC Stage III at presentation. Figure modified with permissions from Mann et al.Citation5

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.